Polymorphic forms of a substituted-quinoxaline-type bridged-piperidine compound
Provided herein are novel crystalline forms of a crystalline compound of Formula (I), which modulates the ORL-1 receptor. The crystalline compounds of Formula (I), compositions thereof, and methods of using thereof that are described herein are particularly useful for treatment, prevention, and mana...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | Tsuno, Naoki Igo, David Fukuda, Mayu Miyake, Naoki Ortiz, Ronnie |
| description | Provided herein are novel crystalline forms of a crystalline compound of Formula (I), which modulates the ORL-1 receptor. The crystalline compounds of Formula (I), compositions thereof, and methods of using thereof that are described herein are particularly useful for treatment, prevention, and management of several sleep disorders. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_NZ776717A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>NZ776717A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_NZ776717A3</originalsourceid><addsrcrecordid>eNrjZPAPyM-pzM0vKsjITFZIyy_KLVbIT1NIVCguTSouySwpLUlN0S0szczLr0jMycxL1S2pLEhVSCrKTEkHShRkFqQCmUBxheT83IL80rwUHgbWtMSc4lReKM3NIOfmGuLsoZtakB-fWlyQmJyal1oS7xdlbm5mbmjuaExQAQCgOTcM</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Polymorphic forms of a substituted-quinoxaline-type bridged-piperidine compound</title><source>esp@cenet</source><creator>Tsuno, Naoki ; Igo, David ; Fukuda, Mayu ; Miyake, Naoki ; Ortiz, Ronnie</creator><creatorcontrib>Tsuno, Naoki ; Igo, David ; Fukuda, Mayu ; Miyake, Naoki ; Ortiz, Ronnie</creatorcontrib><description>Provided herein are novel crystalline forms of a crystalline compound of Formula (I), which modulates the ORL-1 receptor. The crystalline compounds of Formula (I), compositions thereof, and methods of using thereof that are described herein are particularly useful for treatment, prevention, and management of several sleep disorders.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240927&DB=EPODOC&CC=NZ&NR=776717A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240927&DB=EPODOC&CC=NZ&NR=776717A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Tsuno, Naoki</creatorcontrib><creatorcontrib>Igo, David</creatorcontrib><creatorcontrib>Fukuda, Mayu</creatorcontrib><creatorcontrib>Miyake, Naoki</creatorcontrib><creatorcontrib>Ortiz, Ronnie</creatorcontrib><title>Polymorphic forms of a substituted-quinoxaline-type bridged-piperidine compound</title><description>Provided herein are novel crystalline forms of a crystalline compound of Formula (I), which modulates the ORL-1 receptor. The crystalline compounds of Formula (I), compositions thereof, and methods of using thereof that are described herein are particularly useful for treatment, prevention, and management of several sleep disorders.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZPAPyM-pzM0vKsjITFZIyy_KLVbIT1NIVCguTSouySwpLUlN0S0szczLr0jMycxL1S2pLEhVSCrKTEkHShRkFqQCmUBxheT83IL80rwUHgbWtMSc4lReKM3NIOfmGuLsoZtakB-fWlyQmJyal1oS7xdlbm5mbmjuaExQAQCgOTcM</recordid><startdate>20240927</startdate><enddate>20240927</enddate><creator>Tsuno, Naoki</creator><creator>Igo, David</creator><creator>Fukuda, Mayu</creator><creator>Miyake, Naoki</creator><creator>Ortiz, Ronnie</creator><scope>EVB</scope></search><sort><creationdate>20240927</creationdate><title>Polymorphic forms of a substituted-quinoxaline-type bridged-piperidine compound</title><author>Tsuno, Naoki ; Igo, David ; Fukuda, Mayu ; Miyake, Naoki ; Ortiz, Ronnie</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_NZ776717A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2024</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>Tsuno, Naoki</creatorcontrib><creatorcontrib>Igo, David</creatorcontrib><creatorcontrib>Fukuda, Mayu</creatorcontrib><creatorcontrib>Miyake, Naoki</creatorcontrib><creatorcontrib>Ortiz, Ronnie</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Tsuno, Naoki</au><au>Igo, David</au><au>Fukuda, Mayu</au><au>Miyake, Naoki</au><au>Ortiz, Ronnie</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Polymorphic forms of a substituted-quinoxaline-type bridged-piperidine compound</title><date>2024-09-27</date><risdate>2024</risdate><abstract>Provided herein are novel crystalline forms of a crystalline compound of Formula (I), which modulates the ORL-1 receptor. The crystalline compounds of Formula (I), compositions thereof, and methods of using thereof that are described herein are particularly useful for treatment, prevention, and management of several sleep disorders.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_NZ776717A |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | Polymorphic forms of a substituted-quinoxaline-type bridged-piperidine compound |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T14%3A55%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Tsuno,%20Naoki&rft.date=2024-09-27&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ENZ776717A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |